v2.3.0.11
Goodwill and Other Purchased Intangible Assets
6 Months Ended
Jun. 30, 2011
Goodwill and Other Purchased Intangible Assets  
Goodwill and Other Purchased Intangible Assets

7. Goodwill and Other Purchased Intangible Assets

Goodwill

In accordance with the authoritative guidance issued by the FASB on accounting and reporting for acquired goodwill and other intangible assets, the Company performs its annual impairment test of goodwill on October 1 of each year. The Company's goodwill balance of $46.4 million was unchanged at June 30, 2011 when compared to the balance reported at the end of fiscal year 2010.

Intangibles

Other purchased intangible assets consist of the following (in thousands):

 

     June 30, 2011      December 31, 2010  
     Gross
Carrying
Amount
     Write-offs     Accumulated
Amortization
    Net
Carrying
Amount
     Gross
Carrying
Amount
     Accumulated
Amortization
    Net
Balance
 

Customer lists

   $ 22,030       $ —        $ (15,625   $ 6,405       $ 22,030       $ (15,051   $ 6,979   

Purchased technologies

     15,659         —          (9,552     6,107         15,659         (9,005     6,654   

IPR&D

     1,961         (1,681     (280     —           1,961         (140     1,821   

Leases

     47         —          (13     34         47         (9     38   
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 
   $ 39,697       $ (1,681   $ (25,470   $ 12,546       $ 39,697       $ (24,205   $ 15,492   
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

IPR&D represents the fair value of a project that was underway at Xenos at the time of acquisition. The product underlying this IPR&D item was released on June 28, 2010 and the fair value of this intangible asset was amortized on a straight-line basis over the respective estimated useful life of seven years beginning July 2010. During the second quarter of 2011, the Company recorded $1.7 million of in-process research and development ("IPR&D") impairment charges related to this project. This impairment was deemed necessary due to the fact that changes in circumstances indicated to management that the carrying value of the IPR&D may not be recoverable. Based on an analysis of historical sales of the product since its release in the second quarter of fiscal 2010, as well as the calculation of a discounted cash flow analysis projecting expected cash flows through the remaining useful life of the product, it was determined that the IPR&D balance should be impaired down to zero.

Amortization expense of purchased technology and other intangible assets was approximately $632,000 and $789,000 for the quarters ended June 30, 2011 and 2010, respectively. Of this total, approximately $273,000 and $328,000 was related to the amortization of purchased technology. Amortization expense of purchased intangible assets was approximately $1.3 million and $1.4 million for the six months ended June 30, 2011 and 2010, respectively. Of this total, approximately $547,000 and $566,000 was related to the amortization of purchased technologies. Amortization of purchased technology is included in cost of license fees in the accompanying condensed consolidated statements of operations. The expected remaining annual amortization expense is summarized as follows (in thousands):

 

Fiscal Year

   Purchased
Technology and
Intangibles
 

2011 (remainder of year)

   $ 1,124   

2012

     2,250   

2013

     2,250   

2014

     2,250   

2015 and thereafter

     4,672   
  

 

 

 
   $ 12,546